Bayer’s new pill with B vitamin raises questions about safety
When Bayer announced that its newly approved birth control pill Bayaz, with the same active ingredients as its best-selling Yaz pill, also contains a B-vitamin that helps prevent neural tube birth defects such as spina bifida, consumers couldn’t help but scratch their heads. Why load a pill that is 99 percent effective against preventing pregnancy with a vitamin that is prescribed for pregnant women?

“Should I still be on Yasmin?” asks Beth on a Drugs.com forum. The woman has been taking the popular birth control pills for two years and suddenly developed migraines with blurry vision. Soon after, she had knee surgery and developed a very large blood clot in her leg, called a deep vein thrombosis, or DVT. Doctors put her on the blood thinner coumadin and told her to continue taking Yasmin, but Beth is worried. “I’m swelled up like a balloon,” she writes. “Should I really still be on Yasmin?”
Watson Pharmaceuticals has received approval from the Food and Drug Administration (FDA) under the Abbreviated New Drug Application for Zarah, its new oral contraceptive pill that serves as a generic version of Bayer’s best-selling birth control pill Yasmin. Yasmin and its generic equivalents sold approximately $97 million in the U.S. for the twelve months ending June 30, 2010.